Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2024-01-31T19:14:03

Dapagliflozin (5mg), Vildagliptin SR (50mg) DAPA VILDA 50/5 Dapagliflozin and Vildagliptin SR (Sustained Release) are oral medications primarily used in the management of Type 2 diabetes mellitus. Each of these drugs works in a different way to help control blood sugar levels. Dapagliflozin: Class: Dapagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Function: It works by preventing the kidneys from reabsorbing glucose back into the bloodstream. This leads to the excretion of glucose through the urine, thereby lowering blood sugar levels. Usage: It's used not only to improve glycemic control in adults with Type 2 diabetes but also for the treatment of heart failure and to reduce the risk of cardiovascular death in patients with heart disease. Side Effects: Common side effects include urinary tract infections and yeast infections, due to the increased amount of sugar in the urine. It can also potentially lead to dehydration and a rare but serious condition called diabetic ketoacidosis. Vildagliptin SR (Sustained Release): Class: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Function: It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This helps in lowering blood sugar especially after eating. Usage: Typically used in combination with other diabetes medications to improve blood sugar control in adults with Type 2 diabetes. Side Effects: Side effects may include headache, nasopharyngitis, and upper respiratory tract infection. Rarely, it can cause more serious side effects such as pancreatitis and joint pain. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/dapa-vilda-50-5-134374

Dapagliflozin (5mg), Vildagliptin SR (50mg) DAPA VILDA 50/5 Dapagliflozin and Vildagliptin SR (Sustained Release) are oral medications primarily used in the management of Type 2 diabetes mellitus. Each of these drugs works in a different way to help control blood sugar levels. Dapagliflozin: Class: Dapagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Function: It works by preventing the kidneys from reabsorbing glucose back into the bloodstream. This leads to the excretion of glucose through the urine, thereby lowering blood sugar levels. Usage: It's used not only to improve glycemic control in adults with Type 2 diabetes but also for the treatment of heart failure and to reduce the risk of cardiovascular death in patients with heart disease. Side Effects: Common side effects include urinary tract infections and yeast infections, due to the increased amount of sugar in the urine. It can also potentially lead to dehydration and a rare but serious condition called diabetic ketoacidosis. Vildagliptin SR (Sustained Release): Class: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Function: It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This helps in lowering blood sugar especially after eating. Usage: Typically used in combination with other diabetes medications to improve blood sugar control in adults with Type 2 diabetes. Side Effects: Side effects may include headache, nasopharyngitis, and upper respiratory tract infection. Rarely, it can cause more serious side effects such as pancreatitis and joint pain. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/dapa-vilda-50-5-134374

  • 2024-01-31T19:14:03

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us